An observational study in Thyroid Nodule (Benign), sponsored by Assiut University. Status unknown. Open to participants aged Up to 80 Years. Per ClinicalTrials.gov, last updated 2023-03-07.
Sponsored by Assiut University · Observational
To evaluate the clinical outcomes of RFA and MWA for benign thyroid nodules treatment
The thyroid nodule is one of the most common lesions in clinical practice and has been increasingly detected in approximately 50% of the general population by ultrasound (US) examination in the past two decades due to the widespread use of radiological imaging.
Benign thyroid nodules (BTNs) proven cytologically by fine-needle aspiration biopsy (FNAB) account for 85 to 95% of all thyroid nodules.
Despite the fact that the majority of thyroid nodules diagnosed are benign and do not cause significant clinical symptoms, some nodules may lead to compression-related symptoms. In addition, thyrotoxic symptoms may develop due to hyperfunctioning of some nodules.
To date, surgical resection is the main treatment for thyroid nodules. However, it has serious drawbacks such as leading to excessive surgical trauma or hypothyroidism, influencing the aesthetic aspect of the neck, or increasing a post-operative recurrence rate.
RFA has shown good efficacy and safety in the management of thyroid nodule related cosmetic problems and pressure symptoms.
MWA is a newly developed local thermal ablation technique that has fast heating speed, strong coagulation ability and large ablation zone, and has become a great therapeutic method in heat ablation therapy (8) The advantages of ultrasound-guided minimally invasive ablation therapy over the traditional surgery include simpler operation and shorter treatment time. (8)
200 studies on the registry are indexed under Thyroid Nodule; 57 are open to participants now.
This study's planned enrollment of 50 is below the median of 200 across 78 observational studies indexed under Thyroid Nodule.
Browse Thyroid Nodule studies →Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with benign thyroid nodules come to assiut university hospital for treatment
Exclusion Criteria:
Patients with benign thyroid nodules undergo RFA
Procedure: Radiofrequency ablation/Microwave ablation
Patients with benign thyroid nodule undergo MWA
Procedure: Radiofrequency ablation/Microwave ablation
thermal ablation by radiofrequency and Microwave
symptoms score
symptoms score will be assessed by (visual analogue scale) a score from 1 to 10 will be given by the patient according to each symptom including (neck pain , dysphagia , foreign body sensation , discomfort and cough) 1 is the minimum score indicating the best outcome and 10 is the maximum score indicating worst outcome
Time frame: 2 years
thyroid nodule volume reduction
volume reduction ratio VRR assessed by Ultrasound = \[(initial volume - final volume)/initial volume\] x 100.
Time frame: 2 years
cosmetic score
cosmetic score will be measured by the physician (1, no palpable mass; 2, no cosmetic problem but palpable mass; 3, a cosmetic problem on swallowing only; and 4, a readily detected cosmetic problem) 1 indicates the best outcome and 4 indicates the worst outcome
Time frame: 2 years
No study locations are listed for this record.
Plan to share: No
This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assiut University